The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Open accessAbstract
Activating mutations in GNAQ/GNA11, encoding Gαq G proteins, are initiating oncogenic events in uveal melanoma (UM). However, there are no effective therapies for UM. Using an integrated bioinformatics pipeline, we found that PTK2, encoding focal adhesion kinase (FAK), represents a candidate synthetic lethal gene with GNAQ activation. We show that Gαq activates FAK through TRIO-RhoA non-canonical Gαq-signaling, and genetic ablation or pharmacological inhibition of FAK inhibits UM growth. Analysis of the FAK-regulated transcriptome demonstrated that GNAQ stimulates YAP through FAK. Dissection of the underlying mechanism revealed that FAK regulates YAP by tyrosine phosphorylation of MOB1, inhibiting core Hippo signaling. Our findings establish FAK as a potential therapeutic target for UM and other Gαq-driven pathophysiologies that involve unrestrained YAP function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, FAK was reported to positively regulate YAP activity through tyrosine phosphorylation of the YAP upstream modulator MOB1, then dissociating the MOB1/LATS complex.[ 31, 32 ]”
From Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling (2021) · cites this paper as [31]
In the citing paper
“FAK is known to activate and accumulate YAP in cell nucleus through its regulation of the MOB1/LATS1/2 complex, which is an upstream biomarker of YAP signaling[ 31, 32 ]”
From Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationIntegrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Self-citationThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Defining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,317
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–238 of 238
Synthetic Lethal Screen to Identify Molecular Mechanisms that Drive Uveal Melanoma
Recker, K., Norton, S., Sobh, A., Riva, A., Chang, K., Kuznetsov, J. N., Durante, M. A., Faião‐Flores, F., Bennett, R. L., Vakoc, C. R., et al. (2019) · UF Journal of Undergraduate Research · doi:10.32473/ufjur.v21i1.108370
Exostosin-1 Glycosyltransferase Regulates Endoplasmic Reticulum Architecture and DynamicsPreprint
Kerselidou, D., Dohai, B., Nelson, D., Daakour, S., Cock, N. D., Kim, D.-K., Olivet, J., Assal, D. C. E., Jaiswal, A., Saha, D., et al. (2020) · bioRxiv · doi:10.1101/2020.09.02.275925
The ERK signaling pathway returns to the limelight in uveal melanomas
Krossa, I., Ballotti, R., & Bertolotto, C. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12965
Structure, Function, and Inhibition of the Oncogenic RhoGEF Trio
Bandekar, S. J. (2020) · Deep Blue (University of Michigan)
Adjuvant Therapy of Uveal Melanoma
Hernandez-Aya, L. F., & Lutzky, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-78117-0_13
Molecular Basis of Uveal Melanoma and Emerging Therapeutic Targets
Harbour, J. W., & Corrêa, Z. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78117-0_1
Uveal Melanoma: A Review of the Literature and Personal Experiences
Kim, Y. J., Lee, C. S., & Lee, S. C. (2021) · Journal of Retina · doi:10.21561/jor.2021.6.2.65
Present Status of the Therapeutic Approaches to Treat Uveal Melanoma
Mandal, A., Varghese, M. V., & James, J. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_199-1
Faculty Opinions recommendation of Heterotrimeric Gq proteins as therapeutic targets?
Lowe, J. A., III (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737477343.793572066
Uchihara, T., Miyake, K., Yonemura, A., Komohara, Y., Itoyama, R., Koiwa, M., Yasuda, T., Arima, K., Harada, K., Eto, K., et al. (2023) · doi:10.1158/0008-5472.c.6511711
Uchihara, T., Miyake, K., Yonemura, A., Komohara, Y., Itoyama, R., Koiwa, M., Yasuda, T., Arima, K., Harada, K., Eto, K., et al. (2023) · doi:10.1158/0008-5472.c.6511711.v1
Paradis, J. S., Acosta, M., Saddawi‐Konefka, R., Kishore, A., Lubrano, S., Gomes, F., Arang, N., Tiago, M., Coma, S., Wu, X., et al. (2023) · doi:10.1158/1078-0432.c.6529851
Self-citationData from Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma
Wong, D., Luo, P., Znassi, N., Arteaga, D. P., Gray, D., Danesh, A., Han, M., Stutheit-Zhao, E. Y., Pedersen, S., Prokopec, S. D., et al. (2023) · doi:10.1158/2767-9764.c.6551108.v1
Comparative phosphoproteome analysis of primary and metastatic uveal melanoma cell linesPreprint
Glinkina, K., González‐Prieto, R., Teunisse, A. F. A. S., Gelmi, M. C., Jager, M. J., Vertegaal, A. C. O., & Jochemsen, A. G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570407
Identification of multiomics map and key biomarkers in uveal melanoma with chromosome 3 loss
Yong, X., Kang, T., Li, T., Li, S., Hu, X., Yan, X., Zhang, F., Zheng, J., & Yang, Q. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001585
Loss of neurofibromin accelerates uveal and dermal melanoma formation driven by GNAQPreprint
Longakit, A. N., Urtatiz, O., Luty, A., Zhang, C., Hess, C., Yoo, A., Bourget, H., & Raamsdonk, C. D. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.26.600903
Uveal melanoma: molecular-genetic mechanisms of arising and the therapeutic approaches
Zhilnikova, M., Troitskaya, O. S., Novak, D. D., Atamanov, V. V., & Koval, O. A. (2024) · Molecular Biology · doi:10.31857/s0026898424020017
Saakyan, S. V., Svirina, I. V., Tsygankov, А. Y., Бурденный, А. М., & Loginov, V. I. (2024) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2024-17-3-52-57
Wu, Y., Jiang, Y., Jiang, L., Yang, P., Zhou, T., Xia, X., Hou, F., Yuan, Q., Lu, Y., Wei, W., et al. (2025) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2025.106185
Self-citationThe Role of the Mechanosensor Protein YAP in Embryonic Development: From Oogenesis to Neurulation
Parshina, E. A., Оrlov, E. E., & Zaraysky, A. G. (2024) · Russian Journal of Developmental Biology · doi:10.1134/s106236042570002x
Antony, S., Devaiah, B. N., Konaté, M. M., Wu, Y., Jiang, G., Meitzler, J. L., Lu, J., Diebold, B. A., Mallick, D. J., Roy, K., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113714
Roles of miRNAs in Uveal Melanoma
Wang, R., Yang, C., & Hardy, P. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011131
Song, G., Zhou, J., Song, R., Liu, D., Yu, W., Xie, W., Ma, Z., Gong, J., Meng, H., Yang, T., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13010961
Song, G., Zhou, J., Song, R., Liu, D., Yu, W., Xie, W., Ma, Z., Gong, J., Meng, H., Yang, T., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13010970
Song, G., Zhou, J., Song, R., Liu, D., Yu, W., Xie, W., Ma, Z., Gong, J., Meng, H., Yang, T., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13010967
Song, G., Zhou, J., Song, R., Liu, D., Yu, W., Xie, W., Ma, Z., Gong, J., Meng, H., Yang, T., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13010973
Régulation des tyrosine kinases FAK et Pyk2 par les ß-arrestines
Lot, I. (2021) · theses.fr (ABES) · doi:10.70675/44901d9bz7728z47efz816dze698ae966bbd
Functional genomics characterization of genetic predisposing factors in uveal melanoma
Derrien, A. (2021) · theses.fr (ABES) · doi:10.70675/a794a7dfz4352z46f0zb97az064f9ea78e46
Role of SF3B1 Mutations in Uveal Melanoma Oncogenesis
Vivet-Noguer, R. (2021) · theses.fr (ABES) · doi:10.70675/c44979d4z0e88z4775z9cc4zb2a1e95fe749
Uveal melanoma genetic predisposing factors
Verrier, T. (2025) · theses.fr (ABES) · doi:10.70675/af2c121az9a07z49e5z831dzd893d85bef70
Molecular Biomarkers Applied to Treatment of Melanoma Patients
Seervai, R. N. H., Cho, W. C., & Curry, J. L. (2026) · Molecular pathology library · doi:10.1007/978-3-032-18222-7_12
A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma
Seedor, R. S., Terai, M., Koshkin, S., Aplin, A. E., Orloff, M. M., Sharpe-Mills, E., Naccarato, M., Mills, A., Molinolo, A., Gutkind, J. S., et al. (2026) · Cancers · doi:10.3390/cancers18142232
Self-citationA modern review of uveal melanoma: molecular insights, clinical management, and emerging therapies
Dhabhai, B., Beura, A., Bhatankar, J., Imam, A., Sharma, N. K., Rana, A., Sharma, A., Maurya, P. K., Schmidt‐Wolf, I. G. H., Kumar, A., et al. (2026) · Melanoma Research · doi:10.1097/cmr.0000000000001124
Does the ERBB/EGF Signaling Network Serve as a Nexus for Oncogenic Signals in Uveal Melanoma?
Raeesian, N., & Riese, D. J. (2026) · Biomolecules · doi:10.3390/biom16081079
Gao, X., Zhang, Q., Xu, H., Gu, Y., Xia, Q., Zhou, Q., & Bian, J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215110
Zhou, H., Wang, Y., Zhang, S., Yan, X., Chen, H., Jin, S., Chen, W., & Zhang, X. (2026) · Advanced Materials · doi:10.1002/adma.75155
YAP/TAZ as a mechanochemical signal-resolution circuit
Sailis, A. B. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.101960
Metadata
- Authors
- Feng, X., Arang, N., Rigiracciolo, D. C., Lee, J. S., Yeerna, H., Wang, Z., Lubrano, S., Kishore, A., Pachter, J. A., König, G. M., Maggiolini, M., Kostenis, E., Schlaepfer, D. D., Tamayo, P., Chen, Q., Ruppin, E., & Gutkind, J. S.
- Affiliations
- Sichuan University (CN)
- University of California San Diego (US)
- National Institutes of Health (US)
- Verastem (United States) (US)
- University of Bonn (DE)
- University of Calabria (IT)
- Corresponding author
- Lee, Joo Sang
- Chen, Qianming
- Ruppin, Eytan
- Gutkind, J. Silvio
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 35
- Issue
- 3
- Pages
- 457-472.e5
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC6737937
- OpenAlex
- W2911710737
- Cited by
- 237
- References
- 71
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 31 · 2023: 40 · 2022: 36 · 2021: 40 · 2020: 37 · 2019: 17
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Archive of Doctoral Theses and Digital Collections (University of Calabria) (submittedVersion)
- Funders
- NIH (R33CA225291, U01CA217885, P30 CA023100, R01HG009285, 10193SC, CA209891, CA102310, T32GM007752)
- DGE (1650112, T32CA067754-22)
- MOE (B14038)
- National Natural Science Foundation (81672677, 81520108009, 81621062)
- AIRC (IG 21322)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- uveal melanoma, GNAQ, GNA11, focal adhesion kinase, synthetic lethality, Hippo signaling pathway, YAP, MOB1, tyrosine phosphorylation, therapeutic target
- MeSH terms
- Hippo Signaling Pathway, Uveal Melanoma, Animals, Genes, Lethal, Humans, Melanoma, Neoplasm Transplantation, Phosphorylation, Prognosis, Uveal Neoplasms, Signal Transduction, Survival Analysis, Protein Serine-Threonine Kinases, Computational Biology, GTP-Binding Protein alpha Subunits, Gq-G11, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
